Skip to main content
Etropal AD logo

Etropal AD — Investor Relations & Filings

Ticker · ETR ISIN · BG1100001038 LEI · 747800F04CMOK74FIJ68 BSOBGN Manufacturing
Open in API
Filings indexed 84 across all filing types
Latest filing 2024-10-28 Management Reports
Country BG Bulgaria
Listing BSOBGN ETR

About Etropal AD

https://www.etropal.eu/

Etropal AD is a manufacturer of disposable medical devices, primarily focused on providing life-sustaining care for patients with end-stage renal disease. The company's core activities include the research, development, and production of a comprehensive range of hemodialysis consumables, such as capillary dialyzers. In addition to its focus on dialysis solutions, the company is also active in the field of orthopedics and traumatology. This secondary business line involves the manufacturing of endoprostheses, implants, specialized bioceramic materials, and surgical instruments. With over thirty years of experience, Etropal AD offers a broad spectrum of products that meet high standards of safety and quality.

Recent filings

Filing Released Lang Actions
629747-Etropal_Q3_2024_Additional_information.pdf
Management Reports Classification · 99% confidence The document is titled "ДОПЪЛНИТЕЛНА ИНФОРМАЦИЯ КЪМ МЕЖДИНЕН ФИНАНСОВ ОТЧЕТ ЗА ДЕЙНОСТТА НА "ЕТРОПАЛ"АД КЪМ 30.09.2024 Г." (ADDITIONAL INFORMATION TO THE INTERIM FINANCIAL REPORT OF "ETROPAL"AD AS OF 30.09.2024). It explicitly references the reporting period (30.09.2024) and contains detailed sections typical of a periodic financial disclosure, such as changes in accounting policy, group structure, major shareholder data, and litigation status. This structure strongly indicates a comprehensive report for a period shorter than a year, which corresponds to the Interim / Quarterly Report category (IR). Although it is 'additional information', the core content relates to the interim financial reporting requirements.
2024-10-28 Bulgarian
629746-Etropal_Q3_2024_Internal_information.pdf
Regulatory Filings Classification · 95% confidence The document text is very short (728 characters) and appears to be a regulatory disclosure announcement in Bulgarian. It explicitly references Article 7 of Regulation (EU) No 596/2014 concerning market abuse ('пазарната злоупотреба') and states that 'Етропал АД разкрива вътрешна информация' (Etropal AD discloses inside information). This structure—a brief announcement stating that inside information is being disclosed under specific EU regulation—is characteristic of a general regulatory filing or market announcement that doesn't fit the highly specific categories like 10-K, ER, or DIV. Since it is a mandatory disclosure under EU market abuse rules and doesn't fit other specific types (like DIRS, which is for director dealing, or DIV for dividends), the most appropriate fallback category is Regulatory Filings (RNS).
2024-10-28 Bulgarian
629745-SPRAVKA_1_Ind._Etropal_Q3_2024.xls
Interim / Quarterly Report Classification · 19% confidence
2024-10-28 Bulgarian
629744-BEL.Ind. po MSS ETROPAL_Q3.2024_Final.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Explanations to the Interim Financial Report for the period 01.01.2024-30.09.2024' and contains detailed accounting policies, company information, and management structure. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-10-28 Bulgarian
629743-ETROPAL_Ind. Q3_2024_po MSS_Final.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive interim financial report for the company 'Etropal' AD, covering the period from 01.01.2024 to 30.09.2024. It contains detailed financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Statement of Cash Flows, and Statement of Changes in Equity. Since it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2024
2024-10-28 Bulgarian
626371-Etropal_Q2_2024_Prilojenie_4.pdf
Management Reports Classification · 99% confidence The document is written in Bulgarian and references 'НАРЕДБА № 2 от 9.11.2021 г.' (Ordinance No. 2 of 9.11.2021) concerning public offerings and trading of securities. It systematically addresses several mandatory disclosure points (Change in control, Insolvency, Material transactions, Joint ventures, Auditors, Litigation, Shareholdings, Other material events). The final point explicitly refers to the 'Междинния доклад за дейността на "Етропал" АД за второ тримесечие на 2024 г.' (Interim Report of Etropal AD for the second quarter of 2024). This structure strongly indicates a mandatory periodic disclosure filing, likely related to interim financial reporting or significant events during that period, which aligns best with the 'Interim / Quarterly Report' category (IR), or potentially a general regulatory filing (RNS) if it's just a summary of required disclosures. Given that it summarizes key events (or lack thereof) during a reporting period and references the Interim Report, it functions as a required regulatory disclosure document. Since it is not the full 'Interim Report' itself but a structured notification about key events during the period covered by that report, and it doesn't fit perfectly into ER (Earnings Release - usually just highlights) or MDA (Management Discussion & Analysis), the most appropriate general category for mandatory, structured regulatory disclosures that aren't the main financial statements is 'Regulatory Filings' (RNS), as it is a specific regulatory notification format. However, because it covers the reporting period of an interim report and details mandatory disclosures typically found within or alongside an IR, and given the specific nature of the required disclosures (which often accompany an IR filing in some jurisdictions), classifying it as a general Regulatory Filing (RNS) is the safest fallback, as it is a formal regulatory disclosure document. Revisiting the definitions: It is not an ER (Earnings Release - key highlights only), nor is it the full IR (Interim Report). It is a structured disclosure of events. This type of structured disclosure, often mandated by local regulators (like the Bulgarian Financial Supervision Commission), fits best under the general 'Regulatory Filings' (RNS) category, as it is a miscellaneous regulatory announcement that doesn't match the specific financial report types (10-K, IR, ER).
2024-08-28 Bulgarian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.